Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Different-dose decitabine study in intermediate/high-risk myelodysplastic syndrome
ChiCTR-ONRC-12002004Phase 4Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Aug 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of decitabine in myelodysplastic syndrome (MDS) (2 arms), sponsored by Shanghai Sixth People's Hospital. Primary endpoint: overall response rate. Started Aug 2009; status: completed.
02
Drugs
decitabine
03
Conditions
myelodysplastic syndrome (MDS)
Beyond the preview
Go deeper on ChiCTR-ONRC-12002004.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-ONRC-12002004.